Add Row

Add Element

update
update
update
update
update
update
update

Add Element

update

{COMPANY_NAME}

update

Add Element

Home
Categories

August 05.2025

2 Minutes Read

LIfT BioSciences Secures €12 Million to Tackle Treatment Resistance in Cancer

Confident man smiling in maroon scarf, photorealistic portrait, overcoming challenges.

Transforming Cancer Care: LIfT BioSciences Secures Significant Funding

LIfT BioSciences, a pioneering biotech firm located in London, has successfully secured a €12 million grant to advance its groundbreaking research in overcoming treatment resistance in solid tumors. This noteworthy funding comes from Ireland’s Disruptive Technologies Innovation Fund (DTIF) and is the largest grant awarded by the DTIF to date.

Founded in 2016, LIfT BioSciences specializes in neutrophil immunotherapies, particularly their trailblazing Immuno-Modulatory Alpha Neutrophils (IMANs). Targeting critical treatment challenges, these neutrophils are engineered to restore immune function, providing a promising avenue for improving patient outcomes in oncology. Alex Blyth, CEO of LIfT, emphasized that this grant not only enhances their clinical-stage research but also positions the company at the forefront of next-generation cancer immunotherapies. The funds will significantly support manufacturing processes and clinical trials expected to commence in late 2026.

Collaboration with Expertise: A Game-Changer for Cancer Research

The strategic collaboration with the University of Galway and Hooke Bio enhances LIfT’s capacity for innovation. With the University’s vast knowledge in cell therapy development and Hooke Bio’s advanced immuno-analytics, these partnerships are set to accelerate the journey from research to real-world applications.

Paving the Way for Future Innovations in Cancer Treatment

By leveraging advanced technologies such as induced pluripotent stem cell (iPSC) technology, LIfT aims to develop next-generation therapies that could lead to cost-effective, long-term remissions for cancer patients. As cancer treatment continues to evolve, firms like LIfT BioSciences exemplify the transformative potential of targeted immunotherapies in combating one of the most pressing challenges in health care today.

Entrepreneurship & Startups

1 Views

0 Comments

Write A Comment

Related Posts All Posts

How Nara Organics is Changing the Baby Formula Game for Health-Conscious Parents

Update Reshaping Infant Nutrition: The Journey of Nara Organics In a world dominated by cost-cutting techniques, Esther Hallam’s story stands out. After discovering the alarming quality discrepancies in baby formulas available in the U.S., she embarked on a mission to create a trustworthy alternative. Hallam's frustrations grew as she noted the prevalence of unhealthy ingredients like corn syrup and palm oil, questionable additives found in many popular brands of infant formula. The Health Risks of Conventional Formulas Many parents might not realize that choices made by manufacturers can have real impacts on infant health. Studies suggest a link between corn syrup and obesity risk, while palm oil has been found to hinder calcium and fat absorption. Parents are increasingly seeking formulas that prioritize their child's health, leading to a greater demand for cleaner, organic options. Nara Organics: A Clean Alternative Establishing Nara Organics, Hallam collaborated with scientists and pediatric nutritionists over a span of seven years to develop a unique formula that stands apart from traditional options. Officially launched, Nara’s formula is not only USDA-certified but also FDA-registered, ensuring confidence in its quality and safety standards. Free from palm oil, soy, corn syrup, and GMOs, Hallam's creation caters to a new generation of health-conscious parents looking to provide their children with the best possible nutrition. Response from Financial Institutions As corporate responsibility becomes a focal point, financial institutions and investors are closely watching the organic product sector. Nara Organics represents an innovative market opportunity, aligning with consumer desires for transparency and healthier products. Financial institutions may find potential in supporting similar startups that challenge traditional market dynamics. With innovations like Nara Organics entering the market, modern parents can rest a bit easier, assured they have access to options that prioritize their children's health. As the demand for clean nutrition continues to grow, companies that align with these principles stand to thrive in this evolving landscape.

How Müller’s Acquisition of Biotiful Gut Health Transforms the Functional Dairy Market

Update Müller's Strategic Move into Functional Dairy Market Müller UK & Ireland is making headlines with its recent acquisition of Biotiful Gut Health, a brand that pioneered the introduction of kefir to British consumers. This strategic maneuver allows Müller to tap into the rapidly expanding segment of functional dairy products, aligning with the growing demand for health-focused nutrition. The Story Behind Biotiful Founded in 2012 by Natasha Bowes, Biotiful Gut Health began as a passion project that turned into a household name. Despite early rejections on BBC's Dragons' Den, Bowes persisted, educating the UK market about the gut health benefits of kefir. Her determination has helped establish Biotiful as a recognized player in health-conscious products. Müller's Ambitious Growth Strategy With the acquisition, Müller is poised to enhance its portfolio in health and nutrition, a sector that remains competitive and is currently dominated by small, innovative brands. Richard Williams, the CEO of Müller Yogurt and Desserts, underscores the importance of this acquisition by highlighting its potential for growth through increased innovation and improved product quality. What's Next for Biotiful? Bowes will continue to oversee Biotiful's operations in an advisory role, ensuring that the brand retains its consumer-focused approach while benefiting from Müller’s resources. The collaboration is expected to lead to enhanced product offerings and market penetration. Investment Insights for Financial Stakeholders For financial institutions and service providers, this acquisition represents a significant opportunity to understand the dynamics of the functional dairy market, which is becoming increasingly relevant in consumer health trends. Investor interest in brands that support gut health could signal a shift in consumer spending habits, making this sector ripe for investment. This strategic acquisition by Müller reflects their commitment to evolving with consumer preferences and underscores the growing importance of health-oriented products in the dairy market. Stakeholders should monitor this sector closely as it continues to develop.

Steelmaking's New Frontier: Why A Tech Entrepreneur Is Leading The Charge

Update From Social Media to Steel: Daniel Liss's Ambitious ShiftIn an unexpected career pivot, Daniel Liss, co-founder of the innovative social platform Dispo, is diving headfirst into the world of steelmaking. Liss has developed a fervent belief that modernizing this traditional industry could unlock tremendous potential, especially through the integration of artificial intelligence.A Wake-Up Call from War GamesHis journey towards steel began with insightful op-eds on antitrust in social media, which led him to a unique invitation. Liss participated in a war game run by the National War College, focusing on geopolitical tensions regarding Taiwan. It was during this experience that he recognized a core issue: the U.S.'s diminished capacity to produce critical military materials, particularly steel. This realization sparked a shift in his career focus, epitomizing how understanding geopolitical context can influence business decisions.Nemo Industries: Revolutionizing SteelmakingLiss's latest venture, Nemo Industries, is at the intersection of AI and steel production. Designed to modernize steelmaking processes, Nemo aims to utilize AI for optimizing the production of pig iron—a crucial raw material—and addresses the outdated manufacturing techniques prevalent in the industry. According to Liss, “These plants are run on, at best, Excel spreadsheets. At worst, clipboard technology.” By integrating AI into these operations, he believes companies can achieve substantial profit margins, estimated at 20-30% over traditional producers.The Path Ahead for SteelmakingThis leap into the steel industry from a tech background isn't merely about profit; it's a response to broader market needs. With escalating concerns over supply chain vulnerabilities and national security, the revival of steelmaking in the U.S. could prove beneficial not only economically but also strategically. Liss's ambitious vision could pave the way for a blend of technology and traditional manufacturing, addressing both innovation and critical supply needs.Final Thoughts: Why This MattersThe shift from social media to steelmaking is emblematic of the evolving landscape of entrepreneurship. As financial institutions and service providers explore opportunities tied to emerging industries, Liss’s venture serves as a case study in adaptability and foresight. This story underscores the importance of recognizing and addressing industrial gaps, making it a vital narrative for those invested in the future of American manufacturing.

LIfT BioSciences Secures €12 Million to Tackle Treatment Resistance in Cancer

Transforming Cancer Care: LIfT BioSciences Secures Significant Funding

Collaboration with Expertise: A Game-Changer for Cancer Research

Paving the Way for Future Innovations in Cancer Treatment

Terms of Service

Privacy Policy

Core Modal Title